Sinopharm
1099.HK
#2230
Rank
โ‚น756.08 B
Marketcap
โ‚น242.28
Share price
-2.11%
Change (1 day)
21.45%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น213.12 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น213.12 Billion a decrease over its 2023 earnings that were of โ‚น295.44 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น213.12 B-27.86%
2023โ‚น295.44 B-0.73%
2022โ‚น297.61 B-1.72%
2021โ‚น302.81 B11.7%
2020โ‚น271.08 B18.44%
2019โ‚น228.87 B10.85%
2018โ‚น206.48 B3.05%
2017โ‚น200.37 B36.48%
2016โ‚น146.81 B7.11%
2015โ‚น137.07 B12.38%
2014โ‚น121.97 B25.05%
2013โ‚น97.54 B22.54%
2012โ‚น79.60 B35.43%
2011โ‚น58.77 B52.24%
2010โ‚น38.60 B30.99%
2009โ‚น29.47 B60.59%
2008โ‚น18.35 B48.29%
2007โ‚น12.37 B123.29%
2006โ‚น5.54 B